The team at the European Medical Journal is proud to present the latest edition of their flagship publication EMJ 2.4. This eJournal contains a myriad of cutting-edge, peer-reviewed articles from a range of therapeutic areas, including oncology, hepatology, dermatology, and many more. In the spirit of multidisciplinary collaboration, EMJ hopes that by sharing these varied papers, readers will benefit from the innovation and new data being cultivated from across the medical sphere. At the heart of the eJournal is the enlightening special feature, penned by Prof Theo de Reijke, scrutinising the development and implementation of clinical guidelines and concluding with his thoughts on how the processes to create these key texts could be improved.
European Medical Journal 2.4 2017
Latest articles
All articles
7 Mins
13th
March
Does the Gut Microbiome Influence the Efficacy of Psychiatric Drugs?
Altered gut microbiome profiles correlate with anxiety and depression in humans, and work in animal models has identified specific…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
5 Mins
13th
March
Systemic Health Impact of Leaky Barriers in the Oral-Gut-Brain Axis
The human body is a holistic system, interconnected by the circulatory, nervous, lymphatic, endocrine, and immune systems that facilitate…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
5 Mins
13th
March
Intersection of the Upper Gastrointestinal Microbiome and Oesophageal Cancer
The upper gastrointestinal microbiome, a complex ecosystem of microorganisms that have historically been difficult to identify, may play a…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.
5 Mins
13th
March
Infliximab-Induced Multifocal Motor Neuropathy
Multifocal motor neuropathy (MMN) is a rare immune-mediated disorder characterised by progressive, asymmetric muscle weakness…
Rate this content's potential impact on patient outcomes Submit Rating Average rating / 5. Vote count: No votes so far! Be the first to rate this content.